values and preferences for the pharmacologic/nonpharmacologic intervention comparisons being addressed. We recognize that patient preferences are an important part of our treatment recommendations. Findings from the Patient Panel meeting were discussed throughout the Voting Panel provider and patient on a case-by-case basis. For the purposes of these recommendations, severity is considered a broader concept than disease activity in that it encompasses the level of disease activity at a given